Home / 510(k) Clearances / K853279

510(k) K853279

COXSACKIE A2 CF ANTIGEN, A4, A10 & A16 by Hillcrest Biologicals — Product Code GNO

K853279 is an FDA 510(k) premarket notification submitted by Hillcrest Biologicals for the device "COXSACKIE A2 CF ANTIGEN, A4, A10 & A16". The FDA issued a decision of Substantially Equivalent on November 7, 1985. The device falls under product code GNO (Antisera, Cf, Coxsackievirus A 1-24, B 1-6), a Class I device regulated under 21 CFR 866.3145. Hillcrest Biologicals has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
November 7, 1985
Date Received
August 5, 1985
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Antisera, Cf, Coxsackievirus A 1-24, B 1-6
Device Class
Class I
Regulation Number
866.3145
Review Panel
MI
Submission Type

Other clearances by Hillcrest Biologicals

  • K913618 — ARBOVIRUS IGM IFA TEST (December 3, 1992)
  • K913617 — ARBOVIRUS IGG IFA TEST (December 3, 1992)
  • K913906 — Q FEVER IGG IFA TEST (October 21, 1992)
  • K922374 — Q FEVER IGM IFA TEST (October 21, 1992)
  • K900206 — LYME DISEASE IGM ELISA (June 28, 1991)
  • K896594 — EBV VCA ANTIBODY (IGM) (January 16, 1990)
  • K884829 — EBV EARLY ANTIGEN (R+D) (April 12, 1989)
  • K883767 — LYME DISEASE IFA (IGM) (March 15, 1989)
  • K884591 — EBV-VCA ANTIBODY (IGG) (January 24, 1989)
  • K883487 — LYME DISEASE IFA (IGG) (December 13, 1988)

FDA data resources